Fulden Sarac, Sumru Savas, Sefa Sarac, FEHMİ AKCİCEK

Relationship between 25-hydroxyvitamin D Level and Metabolic Control and Albumin Excretion Rate in Elderly Patients with Type 2 Diabetes Mellitus

The aims of the study were 1. to investigate the frequency of 25-hydroxyvitamin D deficiency and 2. to observe the relationships between D vitamin supplementation for 6 months and albümin excretion in elderly patients with type 2 diabetes mellitus. The study population included 100 patients with type 2 DM treated with insulin therapy (mean age 56.1±8.8 yrs) were enrolled in the study. Of 100 patients, 30 (mean age 65.4±6.4 yrs) had low 25(OH)D level. Patients with low 25(OH)D level received 50,000 unit of vitamin D3 orally per three weeks for 6 months. Albumin excretion rate (AER) was measured in patients with low level 25(OH) D before and after D vitamin supplementation In study group (n= 100), 30 patients had low 25(OH)D level. Concentrations of 25(OH)D were; 10 (33.3%) had insufficient vitamin D levels, 19 (63.4%) had deficient levels, 1 (3.3%) had severe deficiency in patients with deficiency. There were statistically significantly differences for plasma levels of HbA1c (p=0.001), postprandial glucose (p=0.0001), triglyceride (p=0.04), total-Cholesterol (p=0.03), LDL-Cholesterol (p=0.02), and HDL-Cholesterol (p=0.001) between D vitamin supplementation. There were high frequency of 25(OH)D deficiency in patients with type 2 diabetic patients. And also, D vitamin suplementation changed metabolic parameters such as triglyceride, total-Cholesterol, LDL-Cholesterol and HDL-Cholesterol, postprandial glucose and HbA1c levels but not albumin excretion rate.

Anahtar Kelimeler:

25-hydroxyvitamin D, diabetes mellitus, albumin excretion rate, metabolic control

Relationship between 25-hydroxyvitamin D Level and Metabolic Control and Albumin Excretion Rate in Elderly Patients with Type 2 Diabetes Mellitus

Keywords:

25-hydroxyvitamin D, diabetes mellitus, albumin excretion rate, metabolic control,

PDF

___

Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320–5.
Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010;33(10): 2238–43.
Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006; 29(10): 2244–6.
Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1C levels with vitamin D status in US adults: data from the National Health and Nutrition Examination Survey. Diabetes Care. 2010;33(6):1236–8.
Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995; 274(21):1683-6.
Marriott BM. Vitamin D supplementation: A word of caution. Ann Int Med. 1997;127(3):231-3.
Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010;39(2):365–79.
Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia. 2005;48(6):1038–50.
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. The effects of calcitriol and nicotinamide on residual pancreatic b-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med. 2006;23(8):920–3.
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insülin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258–61.
Yilmaz H, Kaya M, Sahin M, Delibasi T. Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients. Diabetes Metab Syndr. 2012;6(1):28-31.
Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29(3):650–6.
Joergensen C, Reinhard H, Schmedes A, Hansen PR, Wiinberg N, Petersen CL, Winther K, Parving HH, Jacobsen PK, Rossing P. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care. 2012;35(1):168-72
Barnard K, Colón-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010;8(1):4-33.
Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10(2):94-111.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81.
Marriott BM. Vitamin D supplementation: A word of caution. Ann Int Med. 1997;127(3):231-3.
Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274(21):1683-6.
Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005; 35(5):290-304.
Hollick MF. McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century. Am J Clin Nutr. 1994;60(4):619-30.
Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27(3):181–8.
Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006;29(3):722–4.
Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320–5.
Lee JI, Oh SJ, Ha WC, Kwon HS, Sohn TS, Son HS, Cha BY. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res Clin Pract. 2012;95(1):42-7.
Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010;33(10):2238-43.
De Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-HydroxyVitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50(1):69-77
Bonakdaran S, Hami M, Hatefi A. The effects of calcitriol on albuminuria in patients with type-2 diabetes mellitus. Saudi J Kidney Dis Transpl. 2012;23(6):1215-20. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term Vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633-7.
Scragg R, Sowers M, Bell C. Serum 25-hydroxy Vitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20(7):713-9.
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR, Daly RM. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, populationbased prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab. 2012;97(6):1953-61.
Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55(8):2173-82 Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of Vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258-61.
Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5): 820-5.
Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ. Prospective associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes. 2011;60(11):2947–53.
Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. DiabetesCare. 2005;28(12):2926–32.
Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, Mason J. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;(2):CD004639.